Posted in | News | Copper | Iron Ore

Russia's En+ Forms Joint Venture with Korea Resources for Iron and Copper

En+ Group owned by Russian tycoon Oleg Deripaska declared via an e-mailed statement that it had formed a joint venture with Korea Resources Corp (KORES) to develop a Siberian copper and iron ore deposit in which the Koreans will invest at least $1 billion.

The JV will be aimed at developing the Chinea iron ore field in Siberia.

The South Korean group will invest at least $1 billion and En+ will keep a controlling stake through unit Strikeforce Mining & Resources Ltd., EN+

“The fast-growing Asian markets have already become the global center of commodities and metals consumption,” Artem Volynets, first deputy chief executive officer at En+, said in the statement. “Our partnership with the South Korean consortium to develop the Chinea deposit is a logical step in the further expansion of En+ towards those markets.”

En+ Group's Strikeforce Mining will control 50 percent plus one share in the project, which will develop as En+ claims, ’one of the world's largest iron ore and copper deposits’.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 18). Russia's En+ Forms Joint Venture with Korea Resources for Iron and Copper. AZoMining. Retrieved on May 07, 2024 from https://www.azomining.com/News.aspx?newsID=2229.

  • MLA

    Chai, Cameron. "Russia's En+ Forms Joint Venture with Korea Resources for Iron and Copper". AZoMining. 07 May 2024. <https://www.azomining.com/News.aspx?newsID=2229>.

  • Chicago

    Chai, Cameron. "Russia's En+ Forms Joint Venture with Korea Resources for Iron and Copper". AZoMining. https://www.azomining.com/News.aspx?newsID=2229. (accessed May 07, 2024).

  • Harvard

    Chai, Cameron. 2019. Russia's En+ Forms Joint Venture with Korea Resources for Iron and Copper. AZoMining, viewed 07 May 2024, https://www.azomining.com/News.aspx?newsID=2229.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.